Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Reduced Variability to Aspirin Antiplatelet Effect by the Coadministration of Statins in High-Risk Patients for Cardiovascular Disease.

Tacconelli S, Dovizio M, Di Francesco L, Meneguzzi A, D'Agostino I, Evangelista V, Manarini S, Capone ML, Grossi L, Porreca E, Di Febbo C, Bruno A, Ballerini P, Levantesi G, Fava C, Minuz P, Patrignani P.

Clin Pharmacol Ther. 2018 Jul;104(1):111-119. doi: 10.1002/cpt.1075. Epub 2018 Apr 19.

PMID:
29574792
2.

n-3 PUFAs and heart failure.

Marchioli R, Levantesi G.

Int J Cardiol. 2013 Dec 20;170(2 Suppl 1):S28-32. doi: 10.1016/j.ijcard.2013.06.041. Epub 2013 Sep 6. Review.

PMID:
24012159
3.

n-3 PUFAs in cardiovascular disease.

Marchioli R, Levantesi G.

Int J Cardiol. 2013 Dec 20;170(2 Suppl 1):S33-8. doi: 10.1016/j.ijcard.2013.06.042. Epub 2013 Sep 6. Review.

PMID:
24012154
4.

Why Do We Still Need Large Scale Clinical Trial: The Case of n-3 PUFA.

Marchioli R, Levantesi G.

Front Physiol. 2012 Jun 28;3:202. doi: 10.3389/fphys.2012.00202. eCollection 2012.

5.

Uric acid: a cardiovascular risk factor in patients with recent myocardial infarction.

Levantesi G, Marfisi RM, Franzosi MG, Maggioni AP, Nicolosi GL, Schweiger C, Silletta MG, Tavazzi L, Tognoni G, Marchioli R.

Int J Cardiol. 2013 Jul 15;167(1):262-9. doi: 10.1016/j.ijcard.2011.12.110. Epub 2012 Jan 20.

PMID:
22261690
6.

Glucose and collagen regulate human platelet activity through aldose reductase induction of thromboxane.

Tang WH, Stitham J, Gleim S, Di Febbo C, Porreca E, Fava C, Tacconelli S, Capone M, Evangelista V, Levantesi G, Wen L, Martin K, Minuz P, Rade J, Patrignani P, Hwa J.

J Clin Invest. 2011 Nov;121(11):4462-76. doi: 10.1172/JCI59291. Epub 2011 Oct 17.

7.

Wine consumption and risk of cardiovascular events after myocardial infarction: results from the GISSI-Prevenzione trial.

Levantesi G, Marfisi R, Mozaffarian D, Franzosi MG, Maggioni A, Nicolosi GL, Schweiger C, Silletta M, Tavazzi L, Tognoni G, Marchioli R.

Int J Cardiol. 2013 Mar 10;163(3):282-287. doi: 10.1016/j.ijcard.2011.06.053. Epub 2011 Jul 6.

PMID:
21737162
8.

Uses and benefits of omega-3 ethyl esters in patients with cardiovascular disease.

Levantesi G, Silletta MG, Marchioli R.

J Multidiscip Healthc. 2010 Jul 7;3:79-96.

9.

N-3 polyunsaturated fatty acids in heart failure: mechanisms and recent clinical evidence.

Marchioli R, Silletta MG, Levantesi G, Pioggiarella R, Tognoni G.

Cell Mol Biol (Noisy-le-grand). 2010 Feb 25;56(1):110-30.

PMID:
20196975
10.

Omega-3 fatty acids and heart failure.

Marchioli R, Silletta MG, Levantesi G, Pioggiarella R.

Curr Atheroscler Rep. 2009 Nov;11(6):440-7. Review.

PMID:
19852885
11.

Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial.

Marchioli R, Levantesi G, Silletta MG, Barlera S, Bernardinangeli M, Carbonieri E, Cosmi F, Franzosi MG, Latini R, Lucci D, Maggioni AP, Moretti L, Nicolosi GL, Porcu M, Rossi MG, Tognoni G, Tavazzi L; GISSI-HF Investigators.

Expert Rev Cardiovasc Ther. 2009 Jul;7(7):735-48. doi: 10.1586/erc.09.70.

PMID:
19589110
12.

Coffee consumption and risk of cardiovascular events after acute myocardial infarction: results from the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico)-Prevenzione trial.

Silletta MG, Marfisi R, Levantesi G, Boccanelli A, Chieffo C, Franzosi M, Geraci E, Maggioni AP, Nicolosi G, Schweiger C, Tavazzi L, Tognoni G, Marchioli R; GISSI-Prevenzione Investigators.

Circulation. 2007 Dec 18;116(25):2944-51. Epub 2007 Dec 3.

PMID:
18056527
13.

Meta-analysis of effect of statin treatment on risk of sudden death.

Levantesi G, Scarano M, Marfisi R, Borrelli G, Rutjes AW, Silletta MG, Tognoni G, Marchioli R.

Am J Cardiol. 2007 Dec 1;100(11):1644-50. Epub 2007 Oct 24.

PMID:
18036362
14.

Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial.

Marchioli R, Marfisi RM, Borrelli G, Chieffo C, Franzosi MG, Levantesi G, Maggioni AP, Nicolosi GL, Scarano M, Silletta MG, Schweiger C, Tavazzi L, Tognoni G.

J Cardiovasc Med (Hagerstown). 2007 Sep;8 Suppl 1:S34-7.

PMID:
17876196
15.

Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors.

Mozaffarian D, Marfisi R, Levantesi G, Silletta MG, Tavazzi L, Tognoni G, Valagussa F, Marchioli R.

Lancet. 2007 Aug 25;370(9588):667-75.

PMID:
17720018
16.

Persistent platelet activation in patients with type 2 diabetes treated with low doses of aspirin.

Evangelista V, de Berardis G, Totani L, Avanzini F, Giorda CB, Brero L, Levantesi G, Marelli G, Pupillo M, Iacuitti G, Pozzoli G, di Summa P, Nada E, de Simone G, Dell'Elba G, Amore C, Manarini S, Pecce R, Maione A, Tognoni G, Nicolucci A.

J Thromb Haemost. 2007 Nov;5(11):2197-203. Epub 2007 Aug 7.

17.

A meta-analysis of trials of pulmonary hypertension: a clinical condition looking for drugs and research methodology.

Macchia A, Marchioli R, Marfisi R, Scarano M, Levantesi G, Tavazzi L, Tognoni G.

Am Heart J. 2007 Jun;153(6):1037-47. Review.

PMID:
17540207
18.

Vitamin E increases the risk of developing heart failure after myocardial infarction: Results from the GISSI-Prevenzione trial.

Marchioli R, Levantesi G, Macchia A, Marfisi RM, Nicolosi GL, Tavazzi L, Tognoni G, Valagussa F; GISSI-Prevenzione Investigators.

J Cardiovasc Med (Hagerstown). 2006 May;7(5):347-50.

PMID:
16645413
19.

A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione scoring.

Macchia A, Levantesi G, Borrelli G, Franzosi MG, Maggioni AP, Marfisi R, Scarano M, Tavazzi L, Tognoni G, Valagussa F, Marchioli R; Associazione Nazionale Medici Cardiologi Ospedalieri; Istituto di Ricerche Farmacologiche Mario Negri-Consorzio Mario Negri Sud, Santa Maria Imbaro; Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione Investigators.

Am Heart J. 2006 Mar;151(3):754.e7-754.e17.

PMID:
16504647
20.

Antiarrhythmic mechanisms of n-3 PUFA and the results of the GISSI-Prevenzione trial.

Marchioli R, Levantesi G, Macchia A, Maggioni AP, Marfisi RM, Silletta MG, Tavazzi L, Tognoni G, Valagussa F; GISSI-Prevenzione Investigators.

J Membr Biol. 2005 Jul;206(2):117-28.

PMID:
16456722

Supplemental Content

Loading ...
Support Center